The effect of recall period on reported out-of-pocket health expenditure in Ghana

Background Out-of-pocket health payments (OOPs) are a key indicator of health financing systems’ performance. Measuring OOPs through household surveys is challenging and yet it is the primary source of information in the absence of comprehensive data on user charges in the public sector and market data from the private sector. The choice of the recall period has been identified as a source of bias in previous studies. This study investigates the effect of two different types of recall periods on the agreement between OOPs reported by households and providers.

Methods Households were sampled for the community survey from the Navrongo Health and Demographic Surveillance System, Ghana. Two versions of a health expenditure module were developed differing only in the recall periods, “shorter recall periods”2weeks for medicines and outpatient care, 3monthsfor preventive care and 6months for inpatient care and medical products. The longer recall periods were 4 weeks, 6months and 12months.Households from both community and provider sampling were randomly assigned to the two questionnaires. The providers included the hospital, one clinic and health facilities and drug shops in the area. We estimated the ratio between the overall mean household OOPs and overall mean provider OOPs. We assessed agreement between the individual matched household-provider OOPs using the Bland-Altman analysis.

Findings The short and long recall period versions of the questionnaires were administered to746 and 480 households with matching success to provider records of 72% and 84%, respectively. The most common spending categories were inpatient care and medicines in this sample. The overall mean OOPs reported by the households were higher than provider records for both recall periods. For matched household-provider data, there was no evidence of a difference in the agreement between the household and provider OOPs for inpatient care, the ratio of household to provider for the 12 months recall was estimated to be 0.74 (95% CI 0.45, 1.19; p=0.22) that of the ratio of household to provider for the 6-month period, where less than 1 indicates better agreement. For medicines, the ratio of 4 weeks to 2 weeks was 1.26 (0.93, 1.39; p=0.39).

Conclusion There were considerable challenges in using provider data to assess the accuracy of reported OOPs in this setting. There was no evidence from this study that the agreement between household and provider data differed by recall period, however the confidence intervals of the effect were wide, and an effect cannot be ruled out.